Potential of nanoformulations in malaria treatment

Potential of nanoformulations in malaria treatment

Malaria is caused by the protozoan Plasmodium sp and affects millions of people worldwide. Its clinical form ranges from asymptomatic to potentially fatal and severe. Current treatments include single drugs such as chloroquine, lumefantrine, primaquine, or in combination with artemisinin or its deri...

Full description

Bibliographic Details
Main Authors: Janaina Braga Chaves, Bianca Portugal Tavares de Moraes, Stela Regina Ferrarini, Francisco Noé da Fonseca, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
malaria
treatment
pre-clinical study
nanotechnology
infectious disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.999300/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.999300/full

Similar Items